COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.

Parry, Helen; Bruton, Rachel; Roberts, Thomas; McIlroy, Graham; Damery, Sarah; Sylla, Panagiota; Dowell, Alexander C; Tut, Gokhan; Lancaster, Tara; Bone, David; Willett, Brian; Logan, Nicola; Scott, Sam; Hulme, Sam; Jadir, Azar; Amin, Umayr; Nicol, Sam; Stephens, Christine; Faustini, Sian; Al-Taei, Saly; Richter, Alex; Blakeway, Daniel; Verma, Kriti; Margielewska-Davies, Sandra; Pearce, Hayden; Pratt, Guy; Zuo, Jianmin; Paneesha, Shankara; Moss, Paul

Name:

Publisher version

Abstract

No abstract available

Citation

Parry H, Bruton R, Roberts T, McIlroy G, Damery S, Sylla P, Dowell AC, Tut G, Lancaster T, Bone D, Willett B, Logan N, Scott S, Hulme S, Jadir A, Amin U, Nicol S, Stephens C, Faustini S, Al-Taei S, Richter A, Blakeway D, Verma K, Margielewska-Davies S, Pearce H, Pratt G, Zuo J, Paneesha S, Moss P. COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia. Cancer Cell. 2022 Jun 13;40(6):584-586. doi: 10.1016/j.ccell.2022.05.001. Epub 2022 May 6

Type

Article